An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation-Reference-Cited by-同舟云学术

An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation

Published:1998-11 Issue:11 Volume:5 Page:993-1004
ISSN:1072-8368
Container-title:Nature Structural Biology
language:
Short-container-title:Nat Struct Mol Biol

Author:

Livnah Oded,Johnson Dana L.,Stura Enrico A.,Farrell Francis X.,Barbone Francis P.,You Yun,Liu Kathleen D.,Goldsmith Mark A.,He Wen,Krause Christopher D.,Pestka Sidney,Jolliffe Linda K.,Wilson Ian A.

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry,Structural Biology

Reference45 articles.

1. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

2. A proliferation switch for genetically modified cells

3. Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å

4. Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure

5. Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling and biological evaluation of pegmolesatide, a novel and potent erythropoiesis-stimulating agent;Journal of Asian Natural Products Research;2024-06-11

2. De novo-designed transmembrane proteins bind and regulate a cytokine receptor;Nature Chemical Biology;2024-03-13

3. Prediction of interactions between cell surface proteins by machine learning;Proteins: Structure, Function, and Bioinformatics;2023-12-05

4. Prediction of Interactions between Cell Surface Proteins by Machine Learning;2023-09-14

5. Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering;Pharmaceutics;2023-08-04